Related Experiment Video
Updated: Jun 4, 2026
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Obesity in children
1Sansum Medical Research Institute, Santa Barbara, CA, USA. DrLfshtz@aol.com
Journal of Clinical Research in Pediatric Endocrinology
|February 15, 2011
Summary
Childhood obesity is a growing global concern with serious health consequences. Early intervention through diet and exercise is crucial as adult obesity often begins in childhood.
Area of Science:
- Pediatrics
- Public Health
- Endocrinology
Background:
- Childhood obesity prevalence has surged globally over recent decades.
- Adult obesity frequently originates in childhood, highlighting the pediatric focus needed.
- Obesity in children leads to severe health issues, including insulin resistance, type 2 diabetes, and psychological problems.
Purpose of the Study:
- To emphasize the critical need for early intervention in pediatric obesity.
- To highlight the long-term health implications of childhood obesity.
- To underscore the importance of prevention strategies for childhood obesity.
Main Methods:
- This study is a review of current literature on childhood obesity.
- Analysis of epidemiological data on obesity trends.
- Examination of the contributing factors and consequences of pediatric obesity.
Main Results:
- Childhood obesity is a significant precursor to adult morbidity and mortality.
- Adverse childhood health outcomes include insulin resistance, type 2 diabetes, dyslipidemia, PCOS, and orthopedic/pulmonary issues.
- Both genetic and environmental factors contribute to the development of obesity.
Conclusions:
- Preventing childhood obesity is paramount due to limited effective treatment options.
- Effective strategies involve promoting healthy food management and increased physical activity.
- Prioritizing these interventions is essential for protecting children's long-term health.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:30Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...